Spiros Jamas
Founder presso AOBiome LLC
Profilo
Spiros Jamas is a businessperson who founded AOBiome Therapeutics, Inc. and AOBiome LLC and who has been at the helm of 5 different companies.
He is on the board of ALS Therapy Development Foundation, Inc. and Massachusetts Biotechnology Council and Senior Vice President-Therapeutic Development at AOBiome LLC.
He previously occupied the position of Chief Executive Officer & Director at Alpha-Beta Technology, Inc., President, Chief Executive Officer & Director at Enanta Pharmaceuticals, Inc., Chief Executive Officer & Director at Entera Bio Ltd., Chief Executive Officer at AOBiome Therapeutics, Inc., Chief Executive Officer & Director at Tempero Pharmaceuticals, Inc. and Global Healthcare Analyst at SSgA Funds Management, Inc.
Dr. Jamas received a doctorate and a graduate degree from Massachusetts Institute of Technology and an undergraduate degree from The University of Manchester.
Posizioni attive di Spiros Jamas
Società | Posizione | Inizio |
---|---|---|
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 12/11/2010 |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | Founder | 01/01/2013 |
Precedenti posizioni note di Spiros Jamas
Società | Posizione | Fine |
---|---|---|
ENTERA BIO LTD. | Chief Executive Officer | 15/07/2022 |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Chief Executive Officer | 01/01/2019 |
Tempero Pharmaceuticals, Inc. | Chief Executive Officer | 01/01/2012 |
SSgA Funds Management, Inc.
SSgA Funds Management, Inc. Investment ManagersFinance SSgA Funds Management, Inc. (SSgA FM) is a registered investment advisor and mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1978 and is a subsidiary of State Street Global Advisors, Inc., ultimately held by State Street Corp. (NYSE: STT). SSgA FM provides investment advisory services to US investment companies and certain pooled investment vehicles. | Analyst-Equity | 31/12/2008 |
ENANTA PHARMACEUTICALS, INC. | Chief Executive Officer | 01/01/2004 |
Formazione di Spiros Jamas
The University of Manchester | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ENANTA PHARMACEUTICALS, INC. | Health Technology |
ENTERA BIO LTD. | Health Technology |
Aziende private | 7 |
---|---|
Alpha-Beta Technology, Inc.
Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Alpha-Beta Technology, Inc. engages in the discovery, development and commercialization of novel carbohydrate-based products for the prevention and treatment of infectious disease. It develops a novel class of immune modulation pharmaceutical products composed of complex carbohydrates and is discovering and developing new anti-fungal diagnostics and drugs. In addition, Alpha-Beta has developed a rapid in vitro diagnostic to detect and monitor systemic fungal infections and has an anti-fungal research program to discover direct inhibitors of fungal cell wall synthesis. It is in the development stage and is devoting substantially all of its efforts toward product research and development, raising capital, marketing products under development, clinical trials and manufacturing. The Company was founded on March 2, 1988 and is headquartered in Worcester, MA. | Electronic Technology |
SSgA Funds Management, Inc.
SSgA Funds Management, Inc. Investment ManagersFinance SSgA Funds Management, Inc. (SSgA FM) is a registered investment advisor and mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1978 and is a subsidiary of State Street Global Advisors, Inc., ultimately held by State Street Corp. (NYSE: STT). SSgA FM provides investment advisory services to US investment companies and certain pooled investment vehicles. | Finance |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
Tempero Pharmaceuticals, Inc. | Commercial Services |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | Health Technology |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Health Technology |